Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Pulmonary complications remain a significant challenge for COVID-19 survivors, necessitating advanced diagnostic approaches for long-term assessment. We present a curated, open-access dataset of pulmonary function measurements-including nitric oxide (DLNO) and carbon monoxide (DLCO) diffusing capacities-in 572 post-COVID-19 patients and 72 healthy controls (filtered from an original cohort of 726 survivors and 126 controls). Collected across eight international centres, the data include demographics, spirometry, lung volumes, and 5-6 s single-breath DLNO, DLCO, and alveolar volume (VA). Missing values for total lung capacity were imputed, and low-quality or system-specific (Hyp'Air Compact) measurements were excluded in the filtered dataset. A third subset (333 patients, 54 controls) links these measurements to dyspnoea severity (mMRC scale) for correlation and proportional odds analyses. This resource underpins predictive modeling of post-COVID pulmonary impairment via summed z-scores (DLNO + DLCO) and aims to accelerate validation of NO-CO diagnostics. The freely accessible datasets are provided in both SPSS (.sav) and .csv formats at the Mendeley Data Cloud-based repository and includes nominal, ordinal, and scalar data.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12361787PMC
http://dx.doi.org/10.1016/j.dib.2025.111925DOI Listing

Publication Analysis

Top Keywords

dlno dlco
8
pulmonary
4
pulmonary diffusing
4
diffusing capacity
4
capacity dyspnoea
4
dyspnoea covid-19
4
covid-19 insights
4
insights multicentre
4
multicentre datasets
4
datasets pulmonary
4

Similar Publications

Background: Persistent pulmonary dysfunction is common after COVID-19, yet traditional assessments using carbon monoxide diffusing capacity (DLCO) alone may miss alveolar-capillary impairment.

Objective: To determine whether combining nitric oxide (DLNO) and carbon monoxide (DLCO) diffusing capacities enhances detection of post-COVID-19 lung impairment and whether summed -scores outperform individual measures in classifying affected individuals.

Design And Methods: We conducted an individual participant data meta-analysis using hierarchical mixed-effects modelling.

View Article and Find Full Text PDF

Pulmonary complications remain a significant challenge for COVID-19 survivors, necessitating advanced diagnostic approaches for long-term assessment. We present a curated, open-access dataset of pulmonary function measurements-including nitric oxide (DLNO) and carbon monoxide (DLCO) diffusing capacities-in 572 post-COVID-19 patients and 72 healthy controls (filtered from an original cohort of 726 survivors and 126 controls). Collected across eight international centres, the data include demographics, spirometry, lung volumes, and 5-6 s single-breath DLNO, DLCO, and alveolar volume (VA).

View Article and Find Full Text PDF

Background: Multiple effects of ultrafine particles (UFP) on human subjects are known but there is less knowledge of how relative exposure levels between ultrafine and fine particles as typically encountered in large cities affect lung function and cardiovascular parameters.

Methods: Four sites with high/low levels of ultrafine particles and/or fine particles were selected in the city of Munich, Germany: control area (woodland), urban environment, heavy traffic site, biomass combustion (beech wood). In a randomized cross-over design, 26 young, healthy individuals were exposed at each site over 75 min to atmospheric pollutants, which were monitored continuously, while performing intermittent (5 min per 15 min) light exercise.

View Article and Find Full Text PDF

Asbestos exposure can induce pulmonary fibrosis known as asbestosis, and pleural thickening, as well as various cancers. Although lung diffusion capacity (DL) including nitric oxide (NO) is assumed to be more sensitive than carbon monoxide (CO), its added value in assessment of pneumoconiosis has not been investigated yet. 371 formerly exposed workers visiting the outpatient clinic for assessment including pulmonary function testing with DL and low-dose high resolution computed tomography between 2018 and 2021 were included.

View Article and Find Full Text PDF

Background: Persistent respiratory symptoms and impaired gas exchange are common in patients recovering from COVID-19 pneumonia. The Lung Diffusing Capacity for Carbon Monoxide (DLCO) and Carbon Monoxide Transfer Coefficient (KCO) do not adequately distinguish alveolar membrane dysfunction from vascular abnormalities. This study aimed to characterize persistent diffusion impairment in post-ICU patients with prior SARS-CoV-2 pneumonia and reduced DLCO.

View Article and Find Full Text PDF